Table 3 Antiplatelet/anticoagulation therapy
From: Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?
| Variables | PPCI patients (n = 42) | MM patients (n = 69) | P value |
|---|---|---|---|
| Anti-platelet agents | |||
| Aspirin only | 0 (0) | 9 (13.0) | 0.013 |
| Aspirin + Clopidogrel | 10 (23.8) | 32 (46.4) | 0.017 |
| Aspirin + Ticagrelor | 31 (73.8) | 15 (21.7) | < 0.001 |
| Clopidogrel only | 1 (2.4) | 6 (8.7) | 0.25 |
| Anticoagulation agent | |||
| Warfarin | 1 (2.4) | 2 (2.9) | > 0.99 |
| Direct oral anti-coagulation | 3 (7.1) | 4 (5.8) | > 0.99 |
| Combination therapy | |||
| Clopidogrel + Anticoagulation | 0 (0) | 2 (2.9) | 0.53 |
| Triple therapy | 4 (9.5) | 4 (5.8) | 0.47 |